1,720,973 research outputs found
Livedo racemosa: A striking dermatological sign for the antiphospholipid syndrome
No full text[No abstract available]Amengual O, 2003, RHEUMATOLOGY, V42, P1029, DOI 10.1093-rheumatology-keg273; Asherson RA, 2006, CLIN EXP RHEUMATOL, V24, pS46; ASHERSON RA, 1989, BRIT J DERMATOL, V120, P215; BAGULEY E, 1988, ANN RHEUM DIS, V47, P702, DOI 10.1136-ard.47.8.702; Cervera R, 2002, ARTHRITIS RHEUM, V46, P1019, DOI 10.1002-art.10187; CHAMPION RH, 1960, P ROY SOC MED, V53, P961; DEVOS J, 1992, DERMATOLOGY, V185, P296; Ehrmann S, 1907, WIEN MED WOCHENSCHR, V57, P777; ENGLERT HJ, 1989, AM J MED, V87, P408; Frances C, 1999, MEDICINE, V78, P209, DOI 10.1097-00005792-199907000-00001; Frances C, 2005, ARTHRITIS RHEUM, V52, P1785, DOI 10.1002-art.21041; Frances C, 2000, J AUTOIMMUN, V15, P139, DOI 10.1006-jaut.2000.0418; Gibbs MB, 2005, J AM ACAD DERMATOL, V52, P1009, DOI 10.1016-j.jaad.2004.11.051; HUGHES GRV, 1984, CLIN EXP DERMATOL, V9, P535, DOI 10.1111-j.1365-2230.1984.tb00856.x; Hughes GRV, 1999, ISRAEL MED ASSOC J, V1, P100; HUGHES GRV, 1983, BRIT MED J, V287, P1088; Hughes GRV, 2003, ANN RHEUM DIS, V62, P1127, DOI 10.1136-ard.2003.006163; KALASHNIKOVA LA, 1990, NEUROLOGY, V40, P464; Karassa FB, 2000, QJM-MON J ASSOC PHYS, V93, P169, DOI 10.1093-qjmed-93.3.169; KESTER S, 1992, ANN EMERG MED, V21, P207, DOI 10.1016-S0196-0644(05)80168-4; Khamashta MA, 2000, J AUTOIMMUN, V15, P249, DOI 10.1006-jaut.2000.0421; Kraemer M, 2005, J NEUROL, V252, P1155, DOI 10.1007-s00415-005-0967-9; LEVINE SR, 1988, NEUROLOGY, V38, P798; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM, V54, P301, DOI 10.1002-art.21549; LUBACH D, 1990, J AM ACAD DERMATOL, V22, P633, DOI 10.1016-0190-9622(90)70087-X; MCHUGH NJ, 1988, ANN RHEUM DIS, V47, P110, DOI 10.1136-ard.47.2.110; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111-j.1538-7836.2006.01753.x; Piette WW, 2000, BRIT J DERMATOL, V142, P1080, DOI 10.1046-j.1365-2133.2000.03590.x; Sangle S, 2005, ANN RHEUM DIS, V64, P147, DOI 10.1136-ard.2004.020743; Sangle SR, 2003, ANN RHEUM DIS, V62, P999, DOI 10.1136-ard.62.10.999; Sangle SR, 2005, RHEUMATOLOGY, V44, P372, DOI 10.1093-rheumatolgy-keh490; Sepp N., 2003, DERMATOLOGY, P1651; SEPP N, 1995, AM J SURG PATHOL, V19, P448, DOI 10.1097-00000478-199504000-00006; SHEALY CN, 1970, J AMER MED ASSOC, V212, P1522; SNEDDON IB, 1965, BRIT J DERMATOL, V77, P180, DOI 10.1111-j.1365-2133.1965.tb14628.x; Tietjen GE, 2002, HEADACHE, V42, P352, DOI 10.1046-j.1526-4610.2002.02106.x; Toubi E, 2005, CLIN EXP RHEUMATOL, V23, P499; WEINSTEIN C, 1987, ARCH DERMATOL, V123, P596, DOI 10.1001-archderm.123.5.596; WEST SG, 1995, AM J MED, V99, P153, DOI 10.1016-S0002-9343(99)80135-1; Wohlrab J, 2001, BRIT J DERMATOL, V145, P285, DOI 10.1046-j.1365-2133.2001.04348.x; ZELGER B, 1993, ARCH DERMATOL, V129, P437, DOI 10.1001-archderm.129.4.437; ZELGER B, 1992, HUM PATHOL, V23, P668, DOI 10.1016-0046-8177(92)90323-U40292
Livedo racemosa: A striking dermatological sign for the antiphospholipid syndrome
No full text[No abstract available]Amengual O, 2003, RHEUMATOLOGY, V42, P1029, DOI 10.1093-rheumatology-keg273; Asherson RA, 2006, CLIN EXP RHEUMATOL, V24, pS46; ASHERSON RA, 1989, BRIT J DERMATOL, V120, P215; BAGULEY E, 1988, ANN RHEUM DIS, V47, P702, DOI 10.1136-ard.47.8.702; Cervera R, 2002, ARTHRITIS RHEUM, V46, P1019, DOI 10.1002-art.10187; CHAMPION RH, 1960, P ROY SOC MED, V53, P961; DEVOS J, 1992, DERMATOLOGY, V185, P296; Ehrmann S, 1907, WIEN MED WOCHENSCHR, V57, P777; ENGLERT HJ, 1989, AM J MED, V87, P408; Frances C, 1999, MEDICINE, V78, P209, DOI 10.1097-00005792-199907000-00001; Frances C, 2005, ARTHRITIS RHEUM, V52, P1785, DOI 10.1002-art.21041; Frances C, 2000, J AUTOIMMUN, V15, P139, DOI 10.1006-jaut.2000.0418; Gibbs MB, 2005, J AM ACAD DERMATOL, V52, P1009, DOI 10.1016-j.jaad.2004.11.051; HUGHES GRV, 1984, CLIN EXP DERMATOL, V9, P535, DOI 10.1111-j.1365-2230.1984.tb00856.x; Hughes GRV, 1999, ISRAEL MED ASSOC J, V1, P100; HUGHES GRV, 1983, BRIT MED J, V287, P1088; Hughes GRV, 2003, ANN RHEUM DIS, V62, P1127, DOI 10.1136-ard.2003.006163; KALASHNIKOVA LA, 1990, NEUROLOGY, V40, P464; Karassa FB, 2000, QJM-MON J ASSOC PHYS, V93, P169, DOI 10.1093-qjmed-93.3.169; KESTER S, 1992, ANN EMERG MED, V21, P207, DOI 10.1016-S0196-0644(05)80168-4; Khamashta MA, 2000, J AUTOIMMUN, V15, P249, DOI 10.1006-jaut.2000.0421; Kraemer M, 2005, J NEUROL, V252, P1155, DOI 10.1007-s00415-005-0967-9; LEVINE SR, 1988, NEUROLOGY, V38, P798; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM, V54, P301, DOI 10.1002-art.21549; LUBACH D, 1990, J AM ACAD DERMATOL, V22, P633, DOI 10.1016-0190-9622(90)70087-X; MCHUGH NJ, 1988, ANN RHEUM DIS, V47, P110, DOI 10.1136-ard.47.2.110; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111-j.1538-7836.2006.01753.x; Piette WW, 2000, BRIT J DERMATOL, V142, P1080, DOI 10.1046-j.1365-2133.2000.03590.x; Sangle S, 2005, ANN RHEUM DIS, V64, P147, DOI 10.1136-ard.2004.020743; Sangle SR, 2003, ANN RHEUM DIS, V62, P999, DOI 10.1136-ard.62.10.999; Sangle SR, 2005, RHEUMATOLOGY, V44, P372, DOI 10.1093-rheumatolgy-keh490; Sepp N., 2003, DERMATOLOGY, P1651; SEPP N, 1995, AM J SURG PATHOL, V19, P448, DOI 10.1097-00000478-199504000-00006; SHEALY CN, 1970, J AMER MED ASSOC, V212, P1522; SNEDDON IB, 1965, BRIT J DERMATOL, V77, P180, DOI 10.1111-j.1365-2133.1965.tb14628.x; Tietjen GE, 2002, HEADACHE, V42, P352, DOI 10.1046-j.1526-4610.2002.02106.x; Toubi E, 2005, CLIN EXP RHEUMATOL, V23, P499; WEINSTEIN C, 1987, ARCH DERMATOL, V123, P596, DOI 10.1001-archderm.123.5.596; WEST SG, 1995, AM J MED, V99, P153, DOI 10.1016-S0002-9343(99)80135-1; Wohlrab J, 2001, BRIT J DERMATOL, V145, P285, DOI 10.1046-j.1365-2133.2001.04348.x; ZELGER B, 1993, ARCH DERMATOL, V129, P437, DOI 10.1001-archderm.129.4.437; ZELGER B, 1992, HUM PATHOL, V23, P668, DOI 10.1016-0046-8177(92)90323-U40292
Livedo racemosa: A striking dermatological sign for the antiphospholipid syndrome
No full text[No abstract available]Amengual O, 2003, RHEUMATOLOGY, V42, P1029, DOI 10.1093-rheumatology-keg273; Asherson RA, 2006, CLIN EXP RHEUMATOL, V24, pS46; ASHERSON RA, 1989, BRIT J DERMATOL, V120, P215; BAGULEY E, 1988, ANN RHEUM DIS, V47, P702, DOI 10.1136-ard.47.8.702; Cervera R, 2002, ARTHRITIS RHEUM, V46, P1019, DOI 10.1002-art.10187; CHAMPION RH, 1960, P ROY SOC MED, V53, P961; DEVOS J, 1992, DERMATOLOGY, V185, P296; Ehrmann S, 1907, WIEN MED WOCHENSCHR, V57, P777; ENGLERT HJ, 1989, AM J MED, V87, P408; Frances C, 1999, MEDICINE, V78, P209, DOI 10.1097-00005792-199907000-00001; Frances C, 2005, ARTHRITIS RHEUM, V52, P1785, DOI 10.1002-art.21041; Frances C, 2000, J AUTOIMMUN, V15, P139, DOI 10.1006-jaut.2000.0418; Gibbs MB, 2005, J AM ACAD DERMATOL, V52, P1009, DOI 10.1016-j.jaad.2004.11.051; HUGHES GRV, 1984, CLIN EXP DERMATOL, V9, P535, DOI 10.1111-j.1365-2230.1984.tb00856.x; Hughes GRV, 1999, ISRAEL MED ASSOC J, V1, P100; HUGHES GRV, 1983, BRIT MED J, V287, P1088; Hughes GRV, 2003, ANN RHEUM DIS, V62, P1127, DOI 10.1136-ard.2003.006163; KALASHNIKOVA LA, 1990, NEUROLOGY, V40, P464; Karassa FB, 2000, QJM-MON J ASSOC PHYS, V93, P169, DOI 10.1093-qjmed-93.3.169; KESTER S, 1992, ANN EMERG MED, V21, P207, DOI 10.1016-S0196-0644(05)80168-4; Khamashta MA, 2000, J AUTOIMMUN, V15, P249, DOI 10.1006-jaut.2000.0421; Kraemer M, 2005, J NEUROL, V252, P1155, DOI 10.1007-s00415-005-0967-9; LEVINE SR, 1988, NEUROLOGY, V38, P798; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM, V54, P301, DOI 10.1002-art.21549; LUBACH D, 1990, J AM ACAD DERMATOL, V22, P633, DOI 10.1016-0190-9622(90)70087-X; MCHUGH NJ, 1988, ANN RHEUM DIS, V47, P110, DOI 10.1136-ard.47.2.110; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111-j.1538-7836.2006.01753.x; Piette WW, 2000, BRIT J DERMATOL, V142, P1080, DOI 10.1046-j.1365-2133.2000.03590.x; Sangle S, 2005, ANN RHEUM DIS, V64, P147, DOI 10.1136-ard.2004.020743; Sangle SR, 2003, ANN RHEUM DIS, V62, P999, DOI 10.1136-ard.62.10.999; Sangle SR, 2005, RHEUMATOLOGY, V44, P372, DOI 10.1093-rheumatolgy-keh490; Sepp N., 2003, DERMATOLOGY, P1651; SEPP N, 1995, AM J SURG PATHOL, V19, P448, DOI 10.1097-00000478-199504000-00006; SHEALY CN, 1970, J AMER MED ASSOC, V212, P1522; SNEDDON IB, 1965, BRIT J DERMATOL, V77, P180, DOI 10.1111-j.1365-2133.1965.tb14628.x; Tietjen GE, 2002, HEADACHE, V42, P352, DOI 10.1046-j.1526-4610.2002.02106.x; Toubi E, 2005, CLIN EXP RHEUMATOL, V23, P499; WEINSTEIN C, 1987, ARCH DERMATOL, V123, P596, DOI 10.1001-archderm.123.5.596; WEST SG, 1995, AM J MED, V99, P153, DOI 10.1016-S0002-9343(99)80135-1; Wohlrab J, 2001, BRIT J DERMATOL, V145, P285, DOI 10.1046-j.1365-2133.2001.04348.x; ZELGER B, 1993, ARCH DERMATOL, V129, P437, DOI 10.1001-archderm.129.4.437; ZELGER B, 1992, HUM PATHOL, V23, P668, DOI 10.1016-0046-8177(92)90323-U40292
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Chapter 17 Treatment of Late Pregnancy Complications in the Antiphospholipid Syndrome
No full textThe antiphospholipid syndrome (APS) is characterized by arterial and venous thrombosis and pregnancy complications that include recurrent early pregnancy loss and late adverse pregnancy outcomes such as fetal death, severe preeclampsia, placental insufficiency, and fetal growth restriction. The goals of treatment for APS during pregnancy are to reduce or eliminate the risk of thromboembolic events and to improve maternal and fetal outcome by reducing the risk of these complications. Although the routine use of prophylactic-dose unfractionated heparin or low-molecular-weight heparin plus low-dose aspirin is generally advocated for pregnant women with APS and adverse obstetric outcome, this approach is supported by questionable data since these women are underrepresented in clinical trials. Corticosteroids and intravenous immunoglobulin (IVIG) are not recommended for first-line management of treatment of pregnant women with APS. Warfarin is generally contraindicated, and its use should be limited to special conditions. Since most treatment regimens proposed for women with APS carry a significant risk for both the mother and the fetus, each woman should be extensively counseled, and therapeutic options should be individually tailored based on her individual risk of antiphospholipid antibody (aPL)-mediated complications. © 2009 Elsevier B.V. All rights reserved.ASHERSON RA, 1992, J RHEUMATOL, V19, P508; Asherson RA, 2005, ANN RHEUM DIS, V64, P943, DOI 10.1136-ard.2004.026377; AUGER WR, 1995, AM J MED, V99, P392, DOI 10.1016-S0002-9343(99)80187-9; Bates SA, 2004, CHEST, V126, p627S, DOI 10.1378-chest.126.3_suppl.627S; Branch DW, 2000, AM J OBSTET GYNECOL, V182, P122, DOI 10.1016-S0002-9378(00)70500-X; Branch DW, 2003, OBSTET GYNECOL, V101, P1333, DOI 10.1016-S0029-7844(03)00363-6; BRANCH DW, 1992, OBSTET GYNECOL, V80, P614; CARUSO A, 1993, OBSTET GYNECOL, V82, P970; Clark Erin A S, 2007, Curr Rheumatol Rep, V9, P219, DOI 10.1007-s11926-007-0035-9; Clowse MEB, 2006, ARTHRITIS RHEUM, V54, P3640, DOI 10.1002-art.22159; Clowse MEB, 2006, OBSTET GYNECOL, V107, P293, DOI 10.1097-01.AOG.0000194205.95870.86; COWCHOCK FS, 1992, AM J OBSTET GYNECOL, V166, P1318; Cowchock F.S., 1997, AM J OBSTET GYNECOL, V176, P1099; de Groot PG, 2005, CURR OPIN INFECT DIS, V18, P205, DOI 10.1097-01.qco.0000168379.01272.53; DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016-0002-9378(95)91324-6; Dentali F, 2006, OBSTET GYN CLIN N AM, V33, P375, DOI 10.1016-j.ogc.2006.05.006; Derksen RHWM, 2004, ARTHRITIS RHEUM, V50, P1028, DOI 10.1002-art.20105; Derksen RHWM, 2008, J REPROD IMMUNOL, V77, P41, DOI 10.1016-j.jri.2006.12.003; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136-bmj.38380.674340.E0; El-Haieg DO, 2007, INT J GYNECOL OBSTET, V99, P236, DOI 10.1016-j.ijgo.2007.05.045; Empson M, 2005, COCHRANE DB SYST REV, DOI 10.1002-14651858.CD002859.pub2; Empson M, 2002, OBSTET GYNECOL, V99, P135, DOI 10.1016-S0029-7844(01)01646-5; Erkan D, 2006, RHEUM DIS CLIN N AM, V32, P129, DOI 10.1016-j.rdc.2005.09.004; Erkan D, 2001, ARTHRITIS RHEUM, V44, P1466, DOI 10.1002-1529-0131(200106)44:61466::AID-ART2423.0.CO;2-C; Farquharson RG, 2002, OBSTET GYNECOL, V100, P408, DOI 10.1016-S0029-7844(02)02165-8; Fausett MB, 2001, AM J OBSTET GYNECOL, V185, P148, DOI 10.1067-mob.2001.114690; FRAMPTON G, 1987, LANCET, V2, P1023; Galli M, 2003, BLOOD, V101, P1827, DOI 10.1182-blood-2002-02-0441; Ginsberg JS, 2001, CHEST, V119, p122S, DOI 10.1378-chest.119.1_suppl.122S; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172-JCI18817; Girardi G, 2004, NAT MED, V10, P1222, DOI 10.1038-1121; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084-jem.20061022; Gomez-Puerta JA, 2007, ANN RHEUM DIS, V66, P740, DOI 10.1136-ard.2006.061671; HALL JG, 1980, AM J MED, V68, P122, DOI 10.1016-0002-9343(80)90181-3; Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084-jem.200116116; Hunt BJ, 1998, THROMB HAEMOSTASIS, V79, P1060; James AH, 2008, OBSTET GYNECOL SURV, V63, P49; Jeremić Katarina, 2005, Vojnosanit Pregl, V62, P435, DOI 10.2298-VSP0506435J; Kozer E, 2002, AM J OBSTET GYNECOL, V187, P1623, DOI 10.1067-mob.2002.127376; KUPFERMINC MJ, 1994, OBSTET GYNECOL, V83, P806; Kutteh WH, 1996, AM J OBSTET GYNECOL, V174, P1584, DOI 10.1016-S0002-9378(96)70610-5; Laskin CA, 1997, NEW ENGL J MED, V337, P148, DOI 10.1056-NEJM199707173370302; Lassere M, 2004, THROMB RES, V114, P419, DOI 10.1016-j.thromres.2004.08.006; Le Thi Huong D., 2006, RHEUMATOLOGY, V45, P332; Le Thi Thuong D., 2005, ANN RHEUM DIS, V64, P273; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056-NEJMra002974; Levy RA, 2001, LUPUS, V10, P401, DOI 10.1191-096120301678646137; Lima F, 1996, CLIN EXP RHEUMATOL, V14, P131; LOCKSHIN MD, 1989, AM J OBSTET GYNECOL, V160, P439; LYNCH A, 1994, ANN INTERN MED, V120, P470; MartinezFrias ML, 1997, TERATOLOGY, V56, P241, DOI 10.1002-(SICI)1096-9926(199710)56:4241::AID-TERA23.0.CO;2-1; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111-j.1538-7836.2006.01753.x; MONREAL M, 1994, THROMB HAEMOSTASIS, V71, P7; NelsonPiercy C, 1997, AM J OBSTET GYNECOL, V176, P1062, DOI 10.1016-S0002-9378(97)70403-4; Noble LS, 2005, FERTIL STERIL, V83, P684, DOI 10.1016-j.fertnstert.2004.11.002; Norgard B, 2005, AM J OBSTET GYNECOL, V192, P922, DOI 10.1016-j.ajog.2004.10.598; OGASAWARA M, 1995, AM J REPROD IMMUNOL, V34, P269; Opatrny L, 2006, J RHEUMATOL, V33, P2214; ORNSTEIN MH, 1994, J RHEUMATOL, V21, P1360; Oshiro BT, 1996, OBSTET GYNECOL, V87, P489, DOI 10.1016-0029-7844(95)00498-X; Papageorghiou AT, 2005, CURR OPIN OBSTET GYN, V17, P584, DOI 10.1097-01.gco.0000191898.84567.04; Pattison NS, 2000, AM J OBSTET GYNECOL, V183, P1008, DOI 10.1067-mob.2000.106754; Pauzner R, 2001, THROMB HAEMOSTASIS, V86, P1379; Petri Michelle, 2006, Rheum Dis Clin North Am, V32, P591, DOI 10.1016-j.rdc.2006.05.007; Pettila V, 2002, THROMB HAEMOSTASIS, V87, P182; Pierangeli SS, 2005, ANN NY ACAD SCI, V1051, P413, DOI 10.1196-annals.1361.083; Pierangeli SS, 2001, ARTHRITIS RHEUM, V44, P876, DOI 10.1002-1529-0131(200104)44:4876::AID-ANR1443.0.CO;2-2; Quenby S, 2005, FERTIL STERIL, V83, P691, DOI 10.1016-j.fertnstert.2004.07.978; Rai R, 1997, BRIT MED J, V314, P253; Rand JH, 1997, NEW ENGL J MED, V337, P154, DOI 10.1056-NEJM199707173370303; Rey E, 2003, LANCET, V361, P901, DOI 10.1016-S0140-6736(03)12771-7; RUFFATTI A, 1994, J INTERN MED, V235, P81; Ruffatti A, 2006, THROMB HAEMOSTASIS, V96, P337, DOI 10.1160-TH06-05-0287; Ruiz-Irastorza G, 2001, LUPUS, V10, P597, DOI 10.1191-096120301682430168; Ruiz-Irastorza G, 2001, LUPUS, V10, P241, DOI 10.1191-096120301667789546; Ruiz-Irastorza G, 2007, RHEUM DIS CLIN N AM, V33, P287, DOI 10.1016-j.rdc.2007.02.003; Ruiz-Irastorza G, 2005, ANN NY ACAD SCI, V1051, P606, DOI 10.1196-annals.1361.105; Salmon JE, 2008, J REPROD IMMUNOL, V77, P51, DOI 10.1016-j.jri.2007.02.007; Sanson BJ, 1999, THROMB HAEMOSTASIS, V81, P668; Sebire NJ, 2002, BJOG-INT J OBSTET GY, V109, P570, DOI 10.1111-j.1471-0528.2002.00077.x; Shehata HA, 2001, RHEUM DIS CLIN N AM, V27, P643, DOI 10.1016-S0889-857X(05)70226-X; SILVER RK, 1993, AM J OBSTET GYNECOL, V169, P1411; Simpson LL, 2002, SEMIN PERINATOL, V26, P42, DOI 10.1053-sper.2002.29838; SPINNATO JA, 1995, AM J OBSTET GYNECOL, V172, P690, DOI 10.1016-0002-9378(95)90595-2; Stephenson Mary D, 2004, J Obstet Gynaecol Can, V26, P729; STEVENSON RE, 1980, JAMA-J AM MED ASSOC, V243, P1549, DOI 10.1001-jama.243.15.1549; Takeshita Y, 2001, THER APHER, V5, P22, DOI 10.1046-j.1526-0968.2001.005001022.x; Tincani A, 2003, LUPUS, V12, P524, DOI 10.1191-0961203303lu393oa; Torfs CP, 1996, TERATOLOGY, V54, P84, DOI 10.1002-(SICI)1096-9926(199606)54:284::AID-TERA43.0.CO;2-4; Triolo G, 2003, ARTHRITIS RHEUM, V48, P728, DOI 10.1002-art.10957; Tulppala M, 1997, HUM REPROD, V12, P1567, DOI 10.1093-humrep-12.7.1567; Urbanus RT, 2008, BLOOD REV, V22, P93, DOI 10.1016-j.blre.2007.09.001; Vora Setu K, 2006, J Intensive Care Med, V21, P144, DOI 10.1177-0885066606287041; Walenga JM, 2004, SEMIN THROMB HEMOST, V30, P69; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056-NEJM199505183322003; Werler MM, 2002, AM J EPIDEMIOL, V155, P26, DOI 10.1093-aje-155.1.26; Wetzl RG, 2004, LUPUS, V13, P699, DOI 10.1191-0961203304lu2013oa; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002-1529-0131(199907)42:71309::AID-ANR13.0.CO;2-F; Witter FR, 2007, RHEUM DIS CLIN N AM, V33, P253, DOI 10.1016-j.rdc.2007.02.002; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126-science.287.5452.498; Yasmeen S, 2001, J Matern Fetal Med, V10, P91, DOI 10.1080-71490430210
Variations on the Author
Full text link“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
Full text linkWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
Full text linkWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
- …
